International Conference on Immunometabolic Diseases and Clinical Research - (ICIDCR-27)


11th - 12th February, 2027 | Shah Alam, Malaysia

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

12th January, 2027

Paper Submission Deadline

17th January, 2027

Last Date Of Registration

27th January, 2027

Date Of Conference

11th - 12th February, 2027

Downloads

Call for Papers

The (ICIDCR-27) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Immunometabolism, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Immunometabolic diseases: current challenges
  • Clinical research in immunometabolic disorders
  • Role of inflammation in metabolic diseases
  • Therapeutic strategies for immunometabolic conditions
  • Impact of diet on immunometabolic health
  • Immunometabolic interactions in chronic diseases
  • Biomarkers for immunometabolic disease diagnosis
  • Clinical implications of immune metabolism
  • Innovative treatments for immunometabolic diseases
  • Patient-centered approaches in immunometabolic research
  • Role of exercise in immunometabolic health
  • Microbiome's influence on immunometabolism
  • Immunometabolic diseases in pediatric populations
  • Translational research in immunometabolic disorders
  • Ethical considerations in immunometabolic research
  • Public health strategies for immunometabolic diseases
  • Immunometabolism and cardiovascular health
  • Immunometabolic implications of aging
  • Future directions in immunometabolic research
  • Patient outcomes in immunometabolic clinical trials

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.